Shuttle Pharmaceuticals Holdings (SHPH) Depreciation & Amortization (CF) (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $633340.0 for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 62731.35% year-over-year to $633340.0 in Q1 2026; TTM through Mar 2026 was $633369.0, a 13792.72% increase from a year earlier, with the FY2025 full-year figure at $290107.0, up 5210.4% from the prior year.
• Depreciation & Amortization (CF) climbed to $633340.0 in Q1 2026 per SHPH's latest filing, from $1008.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $633340.0 in Q1 2026 and bottomed at -$979.0 in Q2 2025.
• The 5-year median for Depreciation & Amortization (CF) is $1485.0 (2022), against an average of $40788.9.
• Across the five-year window, Depreciation & Amortization (CF) tumbled 201.77% in 2025 and jumped 62731.35% in 2026, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $1488.0 in 2022, then jumped by 33.27% to $1983.0 in 2023, then fell by 9.43% to $1796.0 in 2024, then plunged by 43.88% to $1008.0 in 2025, then soared by 62731.35% to $633340.0 in 2026.
• Per Business Quant, the three latest SHPH Depreciation & Amortization (CF) figures stand at $633340.0 (Q1 2026), $1008.0 (Q3 2025), and -$979.0 (Q2 2025).